CC BY-NC-ND 4.0 · Sleep Sci 2023; 16(03): e278-e283
DOI: 10.1055/s-0043-1773790
Original Article

Positive Pressure Ventilation Treatment Based on Daytime and Night-time Titration in Patients with Obesity Hypoventilation Syndrome: A Randomized Controlled Trial

1   Pulmonary Division, Department of Internal Medicine, Bamdad Respiratory and Sleep Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
,
Marzieh Ghasemi
2   Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
,
Forogh Soltaninejad
1   Pulmonary Division, Department of Internal Medicine, Bamdad Respiratory and Sleep Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
,
Mehrzad Salmasi
2   Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
› Author Affiliations
Funding/Acknowledgments The present study was supported by the Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Objectives The aim of the present study was to investigate the improvements of gas exchange and excessive daytime sleepiness in patients with obesity hypoventilation syndrome (OHS) in daytime and night-time split polysomnography (DSPSG and NSPSG).

Materials and Methods In the present randomized controlled trial, patients with OHS were enrolled in two DSPSG (51 patients) and NSPSG (50 patients) groups in the Bamdad respiratory and sleep research center in Isfahan, Iran. In both groups, the diagnostic polysomnography (PSG) and titration were conducted in one session according to the guidelines of NSPSG. SpO2, PaCO2, and the Epworth Sleepiness Scale (ESS), were measured initially and 12 weeks after treatment. Furthermore, the PSG parameters and the type of treatments for the two groups were recorded and analyzed.

Results A total of 101 OHS patients (age: 62.02 ± 12.4 year old; 61 females [60.4%]) were evaluated. There were no significant differences regarding BMI, gender, and AHI between groups (p > 0.05). Primary SpO2, PaCO2, and ESS were not significantly different between the two groups. After 12 weeks of treatment by continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BiPAP), there were significant improvement of SpO2, PaCO2, and ESS score (p < 0.001). The amount of change of these variables was not different between groups. Among all variables, only the lower SpO2 and higher PaCO2 were associated with response to BiPAP.

Discussion There were no significant differences in the number of changes of SpO2, PaCO2, and ESS by treatment in the DSPSG and NSPSG groups. Therefore, DSPSG may be considered as a valuable alternative method for the diagnosis and titration in OHS patients.

Clinical Trials IRCT20170512033930N2

Ethics Committee Number

IR.MUI.MED.REC.1399.008.




Publication History

Received: 14 December 2021

Accepted: 10 October 2022

Article published online:
11 September 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Orfanos S, Jaffuel D, Perrin C, Molinari N, Chanez P, Palot A. Switch of noninvasive ventilation (NIV) to continuous positive airway pressure (CPAP) in patients with obesity hypoventilation syndrome: a pilot study. BMC Pulm Med 2017; 17 (01) 50
  • 2 Balachandran JS, Masa JF, Mokhlesi B. Obesity hypoventilation syndrome: epidemiology and diagnosis. Sleep Med Clin 2014; 9 (03) 341-347
  • 3 Masa JF, Pépin J-L, Borel J-C, Mokhlesi B, Murphy PB, Sánchez-Quiroga MÁ. Obesity hypoventilation syndrome. Eur Respir Rev 2019; 28 (151) 180097
  • 4 Borel JC, Guerber F, Jullian-Desayes I. et al. Prevalence of obesity hypoventilation syndrome in ambulatory obese patients attending pathology laboratories. Respirology 2017; 22 (06) 1190-1198
  • 5 Chanda A, Kwon JS, Wolff AJ, Manthous CA. Positive pressure for obesity hypoventilation syndrome. Pulm Med 2012; 2012: 568690
  • 6 Afshar M, Brozek JL, Soghier I. et al. The role of positive airway pressure therapy in adults with obesity hypoventilation syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 2020; 17 (03) 344-360
  • 7 Bosschieter PFN, Schoustra E, de Vries N, Steinbusch MJL, Kasius KM, Ravesloot MJL. Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea. Sleep Breath 2022; 26 (02) 707-715
  • 8 Nowbar S, Burkart KM, Gonzales R. et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004; 116 (01) 1-7
  • 9 McArdle N, Grove A, Devereux G, Mackay-Brown L, Mackay T, Douglas NJ. Split-night versus full-night studies for sleep apnoea/hypopnoea syndrome. Eur Respir J 2000; 15 (04) 670-675
  • 10 Berry RB, Quan SF, Abreu AR. et al. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications: American Academy of Sleep Medicine. 2020
  • 11 Clinical Guidelines for the Manual Titration of Positive Airway Pressure in Patients with Obstructive Sleep Apnea. J Clin Sleep Med 2008; 04 (02) 157-171
  • 12 Epstein LJ, Kristo D, Strollo Jr PJ. et al; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009; 5 (03) 263-276
  • 13 Liendo A, Liendo CH. Comments on split-night polysomnography. Rev Fac Med (Caracas) 2019; 67: 7-8
  • 14 Sopkova Z, Dorkova Z, Tkacova R. Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome. Wien Klin Wochenschr 2009; 121 (11-12): 398-404
  • 15 Yakar F, Yakar A, Sezer M, Erelel M. Role of daytime polysomnography in the diagnosis of sleep apnea syndrome. Tuberk Toraks 2015; 63 (02) 78-85
  • 16 Mizuma H, Sonnenschein W, Meier-Ewert K. Diagnostic use of daytime polysomnography versus nocturnal polysomnography in sleep apnea syndrome. Psychiatry Clin Neurosci 1996; 50 (04) 211-216
  • 17 Goode GB, Slyter HM. Daytime polysomnogram diagnosis of sleep disorders. J Neurol Neurosurg Psychiatry 1983; 46 (02) 159-161
  • 18 Rosenthal L, Nykamp K, Guido P. et al. Daytime CPAP titration: a viable alternative for patients with severe obstructive sleep apnea. Chest 1998; 114 (04) 1056-1060
  • 19 Rudkowski JC, Verschelden P, Kimoff RJ. Efficacy of daytime continuous positive airway pressure titration in severe obstructive sleep apnoea. Eur Respir J 2001; 18 (03) 535-541
  • 20 Lloberes P, Rodríguez B, Roca A. et al. Comparison of conventional nighttime with automatic or manual daytime CPAP titration in unselected sleep apnea patients: study of the usefulness of daytime titration studies. Respir Med 2004; 98 (07) 619-625
  • 21 Al-Jawder S, Bahammam A. Utility of daytime polysomnography for in-patients with suspected sleep-disordered breathing. Neurol Neurochir Pol 2009; 43 (02) 140-147
  • 22 Yeager K, Kern J, Cutrufello N, Begay M, Glasser J. 1273 Does a more personalized approach to desensitization and daytime titrations improve PAP compliance, PAP therapy satisfaction/efficacy, and perhaps even save resources?. Sleep (Basel) 2020; 43 (01) A484
  • 23 Krakow B, Ulibarri V, Melendrez D, Kikta S, Togami L, Haynes P. A daytime, abbreviated cardio-respiratory sleep study (CPT 95807-52) to acclimate insomnia patients with sleep disordered breathing to positive airway pressure (PAP-NAP). J Clin Sleep Med 2008; 4 (03) 212-222
  • 24 Kido K, Tachibana N. The new procedure for manual CPAP titration : the afternoon CPAP titration (aPT). J Med Invest 2021; 68 (1.2): 170-174